(Q50948127)

25 March 2018

title

Trends of survival in neuroblastoma and independent risk factors for survival at a single institution. (English)

1 reference

25 March 2018

1 reference

Saito T

1

1 reference

25 March 2018

Tsunematsu Y

2

1 reference

25 March 2018

Saeki M

3

1 reference

25 March 2018

Honna T

4

1 reference

25 March 2018

Masaki E

5

1 reference

25 March 2018

Kojima Y

6

1 reference

25 March 2018

Miyauchi J

7

1 reference

25 March 2018

publication date

1 September 1997

1 reference

25 March 2018

published in

Pediatric Blood & Cancer

1 reference

25 March 2018

volume

29

1 reference

25 March 2018

issue

3

1 reference

25 March 2018

page(s)

197-205

1 reference

25 March 2018

Cancer incidence, survival, and mortality for children younger than age 15 years

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Population based survival rates for childhood cancer in Britain, 1980-91.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Advances and management of solid tumors in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Complete surgical resection combined with aggressive adjuvant chemotherapy and bone marrow transplantation prolongs survival in children with advanced neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Neuroblastoma: review of the literature and an examination of factors contributing to its enigmatic charcter

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

A proposed staging for children with neuroblastoma.Children's cancer study group A

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Biological variables in thoracic neuroblastoma: a Pediatric Oncology Group study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Neuroblastoma--clinical applications of molecular parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Trends in survival for childhood cancer in Britain diagnosed 1971-85

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

A population-based study of neuroblastoma incidence, survival, and mortality in North America.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Neuroblastomas treated at the four major child oncologic clinics in Denmark 1943-1980: an evaluation of 180 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Neuroblastoma mass screening: The arguments for and against

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Improvements in survival from childhood cancer: results of a population based survey over 30 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Neuroblastoma: a 32-year population-based study--implications for screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

The role of surgery in the management of stage IV neuroblastoma: a single institution study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Results of pediatric oncology group protocol 8104 for infants with stages D and DS neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Current urinary mass screening for catecholamine metabolites at 6 months of age may be detecting only a small portion of high-risk neuroblastomas: a chromosome and N-myc amplification study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Prognostic indicators for neuroblastoma: stage, grade, DNA ploidy, MIB-1-proliferation index, p53, HER-2/neu and EGFr--a survival study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Neuroblastoma: influence of age at diagnosis, stage, tumor site, and sex on prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

An analysis of neuroblastoma at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Disseminated neuroblastoma (stage IV and IV-S) in the first year of life. Outcome related to age and stage. Italian Cooperative Group on Neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

Stage III neuroblastoma over 1 year of age at diagnosis: improved survival with intensive multimodality therapy including multiple alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-911X%28199709%2929%3A3%3C197%3A%3AAID-MPO6%3E3.0.CO%3B2-8

10.1002/(SICI)1096-911X(199709)29:3<197::AID-MPO6>3.0.CO;2-8

21 January 2018

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018